Atrion Corporation  (ATRI)
Other Ticker:  
Price: $316.1500 $7.80 2.530%
Day's High: $319.9999 Week Perf: 2.37 %
Day's Low: $ 294.39 30 Day Perf: -4.86 %
Volume (M): 12 52 Wk High: $ 705.74
Volume (M$): $ 3,636 52 Wk Avg: $535.01
Open: $313.92 52 Wk Low: $274.98

 Market Capitalization (Millions $) 557
 Shares Outstanding (Millions) 2
 Employees 660
 Revenues (TTM) (Millions $) 169
 Net Income (TTM) (Millions $) 21
 Cash Flow (TTM) (Millions $) -26
 Capital Exp. (TTM) (Millions $) 28

Atrion Corporation
Atrion Corporation is a healthcare company that focuses on developing and manufacturing medical devices and specialty products for various clinical applications. Established in 1944, the company was initially known as Allen-Simmons Corporation and later changed its name to Atrion Corporation in 1993, following a merger with Cardiovascular Products, Inc.

With its headquarters in Allen, Texas, Atrion Corporation has a significant global presence, with various subsidiaries and facilities in Canada, Europe, and Asia. The company has a diverse range of product lines, comprising of medical devices, intraocular lenses, inertial navigation systems, and other specialty products.

The medical device business unit of Atrion Corporation designs, develops, and manufactures a wide range of cardiovascular and fluid delivery products. These include catheters, valves, sheaths, introducers, and other devices used in diagnostic and interventional procedures. These devices offer healthcare professionals precise control and improved outcomes, making them the preferred choice in many clinical settings.

Additionally, Atrion Corporation's intraocular lens business unit focuses on the design and manufacturing of lenses used in cataract surgery. The lenses are made from high-quality materials that provide excellent optical clarity and patient comfort, leading to improved visual outcomes.

Another interesting aspect of Atrion Corporation's product line is its inertial navigation systems, which are used in the aerospace and defense industry. These systems are designed to provide accurate guidance and navigation information, making them critical components in various applications, including missile guidance, unmanned aerial systems, and spacecraft.

In terms of financials, Atrion Corporation generates revenues of approximately $155 million annually, with a net income of $38 million. The company is publicly traded on the NASDAQ stock exchange under the symbol "ATRI," and it has a market capitalization of approximately $1 billion.

Overall, Atrion Corporation is a healthcare company that has shown resilience and innovation, particularly in its medical device and intraocular lens product lines. Its dedication to precision, quality, and improved outcomes has made it a trusted name in the healthcare industry, positioning the company for continued growth and success.

   Company Address: One Allentown Parkway Allen 75002 TX
   Company Phone Number: 390-9800   Stock Exchange / Ticker: NASDAQ ATRI
   ATRI is expected to report next financial results on February 06, 2024. Next quarterly dividend pay out on December 15, 2023.


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Aurora Technology Acquisition Corp

Aurora Technology Acquisition Corp Faces Declining Operating Behavior, Raising Concerns in Q3 2023

An Overview of Aurora Technology Acquisition Corp's Third Quarter Earnings
As the July to September 30, 2023 earnings season progresses, various companies across different industries are reporting their financial results. One such industry is the Medical Equipment and Supplies sector, which has seen many corporations release their earnings reports. Among them is Aurora Technology Acquisition Corp (ATAK), which recently announced an operating deficit of -$0.4793 million for the third quarter of 2023.
Comparing this figure to the same period in 2022, we can observe a deteriorating operating deficit. In the third quarter of 2022, ATAK reported an operating deficit of -$0.21933 million. This decline raises questions among market participants about the company's ability to generate revenue.

Vivos Therapeutics Inc

Vivos Therapeutics Inc. Defies Financial Odds in the Demanding Times of September 2023

For the fiscal time-frame closing September 30 2023 Vivos Therapeutics Inc decreased a loss per share of $-1.75 per share compare to $-6.50 a year before and Income per Share improved from $-4.50 per share from the preceding reporting season. The revenue crumbled by -31.748 % to $2.90 million from $4.25 million in the corresponding reporting season a year before and sequentially Revenue decreased by -6.456 % from $3.10 million.

Vystar Corporation

Devastating Blow: Medical Equipment and Supplies Company Suffers Major Setback in Q3 2023 Financial Report

Over the past five days, Vystar Corporation has experienced a significant drop in its stock price, declining by -37.78%. Furthermore, the stock is currently trading -20.9% below its 52-week average. In order to better understand the reasons behind this decline, it is essential to examine Vystar Corporation's financial performance for the recent reporting season, which ended on September 30, 2023.
Earnings Per Share and Revenue:
Vystar Corporation reported a considerable improvement in its financial health compared to the previous year. The loss per share decreased from $-0.23 to $-0.03, while the income per share improved from $-0.04. In terms of revenue, there was a significant decline of -98.311% from $3.57 million to $0.06 million compared to the same reporting season a year prior. However, sequentially, the revenue saw an increase of 67.054% from $0.04 million.

Petvivo Holdings Inc

Petvivo Holdings Inc Experiences Widening Losses in Q2 2024 Amid Decrease in Orders

As an investor closely following Petvivo Holdings Inc, the recent financial results have presented a mixed bag of challenges and opportunities. In the second quarter of 2024, the company experienced lower turnover, resulting in a significant revenue decrease and a larger shortfall per share compared to the previous year. However, there were notable signs of potential growth and increasing demand within the Medical Equipment and Supplies industry.
One of the key financial indicators is the revenue, which decreased by -7.127% to $0.21 million year on year. This decline is concerning for Petvivo Holdings Inc, as it points to potential shortcomings in the company's ability to generate sales. Comparatively, the Medical Equipment and Supplies industry as a whole recorded a top-line rise in the same period, suggesting that Petvivo may be facing certain internal challenges.

Ir Med Inc

Ir Med Inc announced operating profit of $1.197 million, in the third quarter of 2023 financial report

As an observer of the Medical Equipment and Supplies sector, I have thoroughly analyzed the third quarter financial results of Ir Med Inc. The company's performance took center stage in this report, overshadowing the same period in the previous year. Despite operating predominantly in the development phase, Ir Med Inc showcased a bullish quarter, signaling potential growth prospects.
Notably, Ir Med Inc reported an operating profit of $1.197 million for the July to September 30, 2023 quarter, without any reported revenue. This indicates that the company is focusing on developing its services rather than generating immediate revenue. Such a strategic course of action is crucial for a business aiming to establish a strong foundation before entering the market.


Atrion's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com